Skip to main content
. 2022 Oct 3;14(19):4829. doi: 10.3390/cancers14194829
AR androgen receptor
CI confidence interval
CK 5/6 cytokeratin 5/6
EGFR epidermal growth factor receptor
ER estrogen receptor
FoxA1 forkhead box protein A1
HES hematoxylin-eosin-saffron
HER2 human epidermal growth factor receptor 2
HR hazard ratio
IHC immunohistochemistry
IRF8 interferon regulatory factor 8
LAR luminal androgen receptor
MRC-1 mannose receptor 1
OS overall survival
PD-1 programmed cell death 1
PD-L1 programmed cell death ligand 1
PR progesterone receptor
RFS relapse-free survival
TAM tumor-associated macrophage
TIL tumor-infiltrating lymphocyte
TMA tissue microarray
TNBC triple-negative breast cancer